AEON BIOPHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.61 USD | -4.17% |
|
-1.83% | -77.64% |
| May. 16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
| May. 16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
EBIT
- Stock Market
- Equities
- AEON Stock
- Revisions AEON Biopharma, Inc.
